AI in Surgery KēlaHealth offers an AI-enabled surgical intelligence platform that delivers patient-specific predictions, risk stratification, and intervention recommendations, presenting clear cross-sell opportunities with health systems seeking to improve surgical outcomes and operational efficiency.

Strategic Partners Past collaborations with Duke and interest from health systems and MedTech companies suggest fertile ground for expanded pilots and co-development opportunities with large care networks and technology providers.

Funding Momentum With seed funding and a multi‑million Series A, plus NSF SBIR support, there is a narrative of validated technology and financial backing that can be leveraged to accelerate customer adoption, procurement discussions, and reference selling.

Clinical and Financial Value The platform targets reductions in complications and improvements across the surgical journey, enabling ROI discussions around clinical quality, readmission reductions, and throughput gains to appeal to hospital CFOs and operating leaders.

SMB to Enterprise Company size and revenue scale indicate potential to target mid-market to enterprise health systems, with room to craft tailored engagements, pilots, and implementation packages that fit hospital IT, clinical leadership, and procurement processes.